Structural formation of huntingtin exon 1 aggregates probed by small-angle neutron scattering.

In several neurodegenerative disorders, including Huntington's disease, aspects concerning the earliest of protein structures that form along the aggregation pathway have increasingly gained attention because these particular species are likely to be neurotoxic. We used time-resolved small-angle neutron scattering to probe in solution these transient structures formed by peptides having the N-terminal sequence context of mutant huntingtin exon 1. We obtained snapshots of the formed aggregates as the kinetic reaction ensued to yield quantitative information on their size and mass. At the early stage, small precursor species with an initial radius of gyration of 16.1 ± 5.9 Å and average mass of a dimer to trimer were monitored. Structural growth was treated as two modes with a transition from three-dimensional early aggregate formation to two-dimensional fibril growth and association. Our small-angle neutron scattering results on the internal structure of the mature fibrils demonstrate loose packing with ~1 peptide per 4.75 Åβ-sheet repeat distance, which is shown to be quantitatively consistent with a β-helix model. This research provides what we believe to be new insights into the structures forming along the pathway of huntingtin exon 1 aggregation and should assist in determining the role that precursors play in neuronal toxicity.

[1]  J. Marsh,et al.  A two-step path to inclusion formation of huntingtin peptides revealed by number and brightness analysis. , 2010, Biophysical journal.

[2]  G. Rose,et al.  Reassessing random-coil statistics in unfolded proteins. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[3]  Christopher A. Ross,et al.  Huntingtin Spheroids and Protofibrils as Precursors in Polyglutamine Fibrilization* , 2002, The Journal of Biological Chemistry.

[4]  G. Fournet,et al.  Small‐Angle Scattering of X‐Rays , 1956 .

[5]  Richard D. Leapman,et al.  Molecular structural basis for polymorphism in Alzheimer's β-amyloid fibrils , 2008, Proceedings of the National Academy of Sciences.

[6]  T. Chalikian,et al.  On volume changes accompanying conformational transitions of biopolymers. , 1998, Biopolymers.

[7]  Steven Finkbeiner,et al.  Huntingtin Acts in the Nucleus to Induce Apoptosis but Death Does Not Correlate with the Formation of Intranuclear Inclusions , 1998, Cell.

[8]  Dalaver H. Anjum,et al.  Polyglutamine disruption of the huntingtin exon1 N-terminus triggers a complex aggregation mechanism , 2009, Nature Structural &Molecular Biology.

[9]  Georges Belfort,et al.  A universal pathway for amyloid nucleus and precursor formation for insulin , 2009, Proteins.

[10]  An assay for characterizing in vitro the kinetics of polyglutamine aggregation. , 2003, Methods in molecular biology.

[11]  M. Verheul,et al.  Aggregation of β‐lactoglobulin and influence of D2O , 1998 .

[12]  D. Svergun,et al.  CRYSOL : a program to evaluate X-ray solution scattering of biological macromolecules from atomic coordinates , 1995 .

[13]  Heather T. McFarlane,et al.  Atomic structures of amyloid cross-β spines reveal varied steric zippers , 2007, Nature.

[14]  Mehmet Sarikaya,et al.  Hsp70 and Hsp40 attenuate formation of spherical and annular polyglutamine oligomers by partitioning monomer , 2004, Nature Structural &Molecular Biology.

[15]  Zbyszek Otwinowski,et al.  Secondary structure of Huntingtin amino-terminal region. , 2009, Structure.

[16]  J T Finch,et al.  Amyloid fibers are water-filled nanotubes , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[17]  Dmitri I Svergun,et al.  A Helical Structural Nucleus Is the Primary Elongating Unit of Insulin Amyloid Fibrils , 2007, PLoS biology.

[18]  C. Dobson,et al.  Protein misfolding, functional amyloid, and human disease. , 2006, Annual review of biochemistry.

[19]  Andrew F Hill,et al.  Tracking Mutant Huntingtin Aggregation Kinetics in Cells Reveals Three Major Populations That Include an Invariant Oligomer Pool* , 2010, The Journal of Biological Chemistry.

[20]  Leslie M Thompson,et al.  Mutant Huntingtin Fragments Form Oligomers in a Polyglutamine Length-dependent Manner in Vitro and in Vivo* , 2010, The Journal of Biological Chemistry.

[21]  M. Perutz,et al.  Aggregation of proteins with expanded glutamine and alanine repeats of the glutamine-rich and asparagine-rich domains of Sup35 and of the amyloid β-peptide of amyloid plaques , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[22]  M. MacDonald,et al.  Huntingtin: Alive and Well and Working in Middle Management , 2003, Science's STKE.

[23]  S. Hersch,et al.  Huntingtin aggregates may not predict neuronal death in Huntington's disease , 1999 .

[24]  C. T. Lee,et al.  Solution structure of an amyloid-forming protein during photoinitiated hexamer-dodecamer transitions revealed through small-angle neutron scattering. , 2007, Biochemistry.

[25]  Jan Skov Pedersen,et al.  Analysis of small-angle scattering data from colloids and polymer solutions: modeling and least-squares fitting , 1997 .

[26]  Ronald Wetzel,et al.  Polyglutamine homopolymers having 8–45 residues form slablike β‐crystallite assemblies , 2005, Proteins.

[27]  E. Nagata,et al.  Huntingtin is cleaved by caspases in the cytoplasm and translocated to the nucleus via perinuclear sites in Huntington's disease patient lymphoblasts , 2005, Neurobiology of Disease.

[28]  G. McRae,et al.  A three-stage kinetic model of amyloid fibrillation. , 2007, Biophysical journal.

[29]  M. Hayden,et al.  Absence of behavioral abnormalities and neurodegeneration in vivo despite widespread neuronal huntingtin inclusions. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[30]  Pawel Sikorski,et al.  New model for crystalline polyglutamine assemblies and their connection with amyloid fibrils. , 2005, Biomacromolecules.

[31]  Peter S. Harper,et al.  Huntington's disease , 1991 .

[32]  R. Wetzel,et al.  Polyglutamine aggregation behavior in vitro supports a recruitment mechanism of cytotoxicity. , 2001, Journal of molecular biology.

[33]  G P Bates,et al.  Self-assembly of polyglutamine-containing huntingtin fragments into amyloid-like fibrils: implications for Huntington's disease pathology. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[34]  D. M. Morgan,et al.  Structure of the β-Amyloid(10-35) Fibril , 2000 .

[35]  M. Diamond,et al.  Polyglutamine diseases: emerging concepts in pathogenesis and therapy. , 2007, Human molecular genetics.

[36]  L. Raymond,et al.  Cleavage at the Caspase-6 Site Is Required for Neuronal Dysfunction and Degeneration Due to Mutant Huntingtin , 2006, Cell.